BR0212274A - Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma - Google Patents

Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma

Info

Publication number
BR0212274A
BR0212274A BR0212274-0A BR0212274A BR0212274A BR 0212274 A BR0212274 A BR 0212274A BR 0212274 A BR0212274 A BR 0212274A BR 0212274 A BR0212274 A BR 0212274A
Authority
BR
Brazil
Prior art keywords
glaucoma
treatment
feminizing
agents
estrogens
Prior art date
Application number
BR0212274-0A
Other languages
English (en)
Inventor
Iok-Hou Pang
Abbot F Clark
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0212274A publication Critical patent/BR0212274A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"USO DE ESTROGêNIOS NãO-FEMINILIZANTES COMO AGENTES RETINOPROTETORES PARA O TRATAMENTO DE GLAUCOMA". A invenção provê composições farmacêuticas contendo estrogênio não-feminilizante e processos de uso destas composições para prevenir ou melhorar dano de nervo ótico e retina associado com glaucoma.
BR0212274-0A 2001-09-05 2002-09-03 Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma BR0212274A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31722501P 2001-09-05 2001-09-05
PCT/US2002/027969 WO2003020284A1 (en) 2001-09-05 2002-09-03 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma

Publications (1)

Publication Number Publication Date
BR0212274A true BR0212274A (pt) 2004-10-19

Family

ID=23232682

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212274-0A BR0212274A (pt) 2001-09-05 2002-09-03 Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma

Country Status (17)

Country Link
EP (1) EP1423125B1 (pt)
JP (1) JP2005501888A (pt)
KR (1) KR100894385B1 (pt)
CN (1) CN1551773A (pt)
AR (1) AR038451A1 (pt)
AT (1) ATE371455T1 (pt)
AU (1) AU2002326807B2 (pt)
BR (1) BR0212274A (pt)
CA (1) CA2458468C (pt)
DE (1) DE60222143T2 (pt)
ES (1) ES2289134T3 (pt)
HK (1) HK1064947A1 (pt)
MX (1) MXPA04002098A (pt)
PL (1) PL206249B1 (pt)
TW (1) TWI320712B (pt)
WO (1) WO2003020284A1 (pt)
ZA (1) ZA200401313B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040214806A1 (en) 2002-09-03 2004-10-28 Iok-Hou Pang Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
CA2527175A1 (en) * 2003-04-18 2004-10-28 Advanced Medicine Research Institute Remedies for diseases to be applied to eye
WO2004093882A1 (ja) * 2003-04-18 2004-11-04 Advanced Medicine Research Institute 眼に適用する疾患治療剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2123405C (en) * 1991-11-22 2008-01-15 Abbot F. Clark Angiostatic steroids
US6197833B1 (en) * 1995-07-24 2001-03-06 Apollo Biopharmaceutics, Inc. Neuroprotective effects of polycyclic phenolic compounds
US5521168A (en) * 1994-10-13 1996-05-28 Alcon Laboratories, Inc. Estrogen metabolites for lowering intraocular pressure
WO2002042319A2 (en) * 2000-11-27 2002-05-30 Entremed, Inc. 2-substituted estrogens as antiangiogenic agents

Also Published As

Publication number Publication date
ES2289134T3 (es) 2008-02-01
ZA200401313B (en) 2005-05-11
TWI320712B (en) 2010-02-21
CA2458468A1 (en) 2003-03-13
WO2003020284A1 (en) 2003-03-13
EP1423125A4 (en) 2005-02-09
HK1064947A1 (en) 2005-02-08
KR20040033012A (ko) 2004-04-17
AR038451A1 (es) 2005-01-19
PL206249B1 (pl) 2010-07-30
CA2458468C (en) 2010-08-24
AU2002326807B2 (en) 2007-08-23
EP1423125B1 (en) 2007-08-29
MXPA04002098A (es) 2004-06-07
DE60222143D1 (de) 2007-10-11
DE60222143T2 (de) 2008-06-05
ATE371455T1 (de) 2007-09-15
EP1423125A1 (en) 2004-06-02
CN1551773A (zh) 2004-12-01
PL374243A1 (en) 2005-10-03
KR100894385B1 (ko) 2009-04-22
JP2005501888A (ja) 2005-01-20

Similar Documents

Publication Publication Date Title
ATE300306T1 (de) Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung
PA8657201A1 (es) Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
BR0213358A (pt) Uso de flibanserina
BR0115102A (pt) 1-aril- ou 1-alquilsulfonil-heterociclilbenzazóis como ligantes 5-hidroxitriptamina-6
DOP2002000429A (es) Imidazotriazinas
BR0312421A (pt) Uso de inibidores de cept e opcionalmente inibidores hmg coa redutase e/ou agentes anti-hipertensivos
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
HUP0400548A2 (hu) Belső szemnyomást csökkentő hatóanyag-kombinációk alkalmazása glaukoma kezelésére szolgáló gyógyszerkészítmények előállítására
DE69930271T8 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
BRPI0407693A (pt) uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
BR0212274A (pt) Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma
BRPI0407742A (pt) uso de glicocorticóides para preparação de formulação utilizáveis no tratamento de angiogênese ocular patológica, bem como formulção assim obtida
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
HUP0204208A2 (hu) Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény
HUP0000110A2 (hu) Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
EP1482922A4 (en) AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERS
SE8901149D0 (sv) Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
HK1050203A1 (en) Novel fusidic acid derivatives.
PA8471901A1 (es) Derivados de 2"-desoxi higromicina

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 31/56

Ipc: A61K 31/56 (2011.01), A61P 27/06 (2011.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.